Skip to main content

Tower Research Capital LLC (TRC)

Position in OVID — Ovid Therapeutics Inc.

CIK 1533421 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$16,581
-$820 QoQ
Shares Held
6,164
-42.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 131 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OVID Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,467,357 across 465 Biotechnology names. OVID ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OVID

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,581 6,164
2025-12-31 $17,401 10,676
2025-09-30 $3,047 2,344
2025-06-30 $17,001 51,520
2025-03-31 $7,439 23,846
2024-12-31 $9,190 9,840
2024-09-30 $9,795 8,301
2024-06-30 $10,902 14,177
2024-03-31 $73,610 24,135
2023-12-31 $14,112 4,383
2023-09-30 $15,502 4,037
2023-06-30 $11,440 3,488
2023-03-31 $13,699 5,310
2022-12-31 $37,786 20,316
2022-09-30 $58,999 32,065
2022-06-30 $38,706 18,003
2022-03-31 $12,538 3,993
2021-12-31 $12,137 3,781
2021-09-30 $25,169 7,491
2021-06-30 $13,778 3,524
2021-03-31 $37,940 9,438
2020-12-31 $98,306 42,557
2020-09-30 $232,734 40,546
2020-06-30 $15,661 2,125
2020-03-31 $32,681 10,967